Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Salirasib to Treat Non-Small Cell Lung Cancer

This study has been completed.
Sponsor:
Information provided by:
Concordia Pharmaceuticals, Inc
ClinicalTrials.gov Identifier:
NCT00531401
First received: September 17, 2007
Last updated: June 8, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)